Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Maier

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of the American Chemical Society|September 23, 2017
4'-C-Methoxy-2'-deoxy-2'-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene SilencingElise Malek-Adamian, Dale C Guenther, Shigeo Matsuda, et al.
Experimental Neurology|November 29, 2011
Widespread suppression of huntingtin with convection-enhanced delivery of siRNADavid K Stiles, Zhiming Zhang, Pei Ge, et al.
Journal of the American Chemical Society|August 28, 2023
Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAsShigeo Matsuda, Saikat Bala, Jen-Yu Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2012
Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particlesTomoko Nakayama, James S Butler, Alfica Sehgal, et al.
Research Square|December 23, 2024
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancersBrandon M Lehrich, Evan R Delgado, Tyler M Yasaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 22, 2021
The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of <i>N</i>-Acetylgalactosamine-Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to HumanRobin McDougall, Diane Ramsden, Sagar Agarwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primatesMaria Frank-Kamenetsky, Aldo Grefhorst, Norma N Anderson, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of the American Chemical Society|September 23, 2017
4'-C-Methoxy-2'-deoxy-2'-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene SilencingElise Malek-Adamian, Dale C Guenther, Shigeo Matsuda, et al.
Experimental Neurology|November 29, 2011
Widespread suppression of huntingtin with convection-enhanced delivery of siRNADavid K Stiles, Zhiming Zhang, Pei Ge, et al.
Journal of the American Chemical Society|August 28, 2023
Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAsShigeo Matsuda, Saikat Bala, Jen-Yu Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2012
Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particlesTomoko Nakayama, James S Butler, Alfica Sehgal, et al.
Research Square|December 23, 2024
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancersBrandon M Lehrich, Evan R Delgado, Tyler M Yasaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 22, 2021
The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of <i>N</i>-Acetylgalactosamine-Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to HumanRobin McDougall, Diane Ramsden, Sagar Agarwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primatesMaria Frank-Kamenetsky, Aldo Grefhorst, Norma N Anderson, et al.
Pageof 4